CAH
NYSE · Health Care
Cardinal Health Inc
$271.72
+3.90 (+1.46%)
CAH News5 articles
Cardinal Health Stock Slides 4.5% as Insider Sales Raise Buyback Doubts
Cardinal Health shares dropped 4.5% premarket after $60M in insider sales, sparking concerns about buyback support. Analysts stay optimistic with a $270.94 price target.
Cardinal Health Soars on Strong 2027 Outlook Despite Cash Flow Dip
Cardinal Health (CAH) shares climbed 3.6% premarket after the company issued FY2027 adjusted EPS guidance of $12.40-$12.60, above consensus, despite a projected 25% decline in free cash flow.
Cardinal Health Stock Hits Record High on Strong Fiscal 2027 Outlook
Cardinal Health shares surged to a record high after the company issued a fiscal 2027 earnings forecast that exceeded analyst expectations, driven by strong segment performance.
Medline's $2.7B Secondary Offering Tests Post-IPO Demand
Medline Inc. shareholders sold 72.55 million Class A shares at $37 each in an upsized secondary offering, with the stock closing at $37.01 on Friday. The deal closes May 28.
Medline's $2.7B Secondary Offering Tests Post-IPO Demand
Medline's $2.68 billion secondary offering, upsized from 60 million shares, prices at $37 each, with the stock holding near that level.